Challenges in the neoadjuvant radiation of rectal cancer by R. Glynne-Johns
Channel: AIS Channel
Date: 2015-06-10

Preoperative chemoradiation (CRT) has been the standard of care for all patients with clinical stage II and III rectal cancer; this is due to benefits such as a low rate of local recurrence, acceptable toxicity, potential sphincter preservation and potential organ preservation.  Some heterogeneous data are currently available that must be analyzed carefully to obtain the best results for the patients.

This is an excerpt from AISChannel.com. To watch the full video go here:
http://aischannel.com/society/challenges-in-the-neoadjuvant-radiation-of-rectal-cancer/